Drug profile · INN
ibuprofen lysine
NEOPROFEN
ibuprofen lysine (NEOPROFEN) is a cyclooxygenase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — ibuprofen lysine
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ibuprofen lysine (NEOPROFEN) is a cyclooxygenase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ibuprofen lysine?
ibuprofen lysine (NEOPROFEN) is a cyclooxygenase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ibuprofen lysine?
NEOPROFEN is a marketed brand name for ibuprofen lysine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibuprofen lysine?
ibuprofen lysine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.